Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)

Clin Endocrinol (Oxf). 2010 Jul;73(1):30-4. doi: 10.1111/j.1365-2265.2009.03766.x. Epub 2009 Dec 18.

Abstract

Objective: To describe mortality and disease-specific morbidities in patients with mild primary hyperparathyroidism (PHPT).

Design: Retrospective population-based observational study.

Setting: Tayside, Scotland, from 1997 to 2006.

Participants: Patients with mild PHPT were selected from a predefined PHPT cohort between 1997 and 2006.

Main outcome measures: Standardised mortality ratios (SMRs) were examined for all-cause mortality, as well as cardiovascular and cancer mortality. Standardised morbidity ratios and standardised incidence ratios were also calculated for eleven observed co-morbidities.

Results: In total, there were 1683 (69.1% female) patients identified with mild PHPT in Tayside. Patients were found to have an increased risk of all-cause mortality and cardiovascular mortality (SMR-all cause 2.62, 95% CI 2.39-2.86; SMR-cardiovascular 2.68, 95% CI 2.34-3.05). Patients with mild PHPT had a significantly increased risk of developing cardiovascular and cerebrovascular disease, renal dysfunction and fractures compared to the age- and sex-adjusted general population.

Conclusions: Mortality and morbidity were increased for patients with mild untreated PHPT, which is similar to more severe PHPT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Calcium / blood
  • Cardiovascular Diseases / epidemiology
  • Cerebrovascular Disorders / epidemiology
  • Comorbidity
  • Female
  • Fractures, Bone / epidemiology
  • Humans
  • Hyperparathyroidism, Primary / epidemiology*
  • Hyperparathyroidism, Primary / mortality
  • Male
  • Middle Aged
  • Morbidity
  • Retrospective Studies
  • Scotland / epidemiology

Substances

  • Calcium